ROX monitoring in critical COVID-19 patients treated with high flow oxygen: A real added value compared to the respiratory rate?

Detalles Bibliográficos
Autores principales: Garnier, M., Blez, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266510/
https://www.ncbi.nlm.nih.gov/pubmed/34312119
http://dx.doi.org/10.1016/j.pulmoe.2021.06.011
_version_ 1783719962697793536
author Garnier, M.
Blez, D.
author_facet Garnier, M.
Blez, D.
author_sort Garnier, M.
collection PubMed
description
format Online
Article
Text
id pubmed-8266510
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U.
record_format MEDLINE/PubMed
spelling pubmed-82665102021-07-09 ROX monitoring in critical COVID-19 patients treated with high flow oxygen: A real added value compared to the respiratory rate? Garnier, M. Blez, D. Pulmonology Correspondence Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. 2021 2021-07-09 /pmc/articles/PMC8266510/ /pubmed/34312119 http://dx.doi.org/10.1016/j.pulmoe.2021.06.011 Text en © 2021 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Garnier, M.
Blez, D.
ROX monitoring in critical COVID-19 patients treated with high flow oxygen: A real added value compared to the respiratory rate?
title ROX monitoring in critical COVID-19 patients treated with high flow oxygen: A real added value compared to the respiratory rate?
title_full ROX monitoring in critical COVID-19 patients treated with high flow oxygen: A real added value compared to the respiratory rate?
title_fullStr ROX monitoring in critical COVID-19 patients treated with high flow oxygen: A real added value compared to the respiratory rate?
title_full_unstemmed ROX monitoring in critical COVID-19 patients treated with high flow oxygen: A real added value compared to the respiratory rate?
title_short ROX monitoring in critical COVID-19 patients treated with high flow oxygen: A real added value compared to the respiratory rate?
title_sort rox monitoring in critical covid-19 patients treated with high flow oxygen: a real added value compared to the respiratory rate?
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266510/
https://www.ncbi.nlm.nih.gov/pubmed/34312119
http://dx.doi.org/10.1016/j.pulmoe.2021.06.011
work_keys_str_mv AT garnierm roxmonitoringincriticalcovid19patientstreatedwithhighflowoxygenarealaddedvaluecomparedtotherespiratoryrate
AT blezd roxmonitoringincriticalcovid19patientstreatedwithhighflowoxygenarealaddedvaluecomparedtotherespiratoryrate

Ejemplares similares